Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission ...
Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...
The University of California, Irvine, which already has won much acclaim in stem cell research, recently received further confirmation of its status as an “alpha” in the industry. The California ...
Allogene Therapeutics is a clinical-stage biotech developing allogeneic CAR T therapies for cancer and autoimmune diseases, with a focus on Cema-cel for LBCL. ALLO's advanced gene-editing platforms, ...
For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says. Scientists at Duke ...
Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies that could help oncology and immunology patients. Their pipeline has 3 interesting Phase 1 candidates for SLE, ...
Beta cells play a key role in the pathogenesis of both Type 1 and Type 2 diabetes. However, pancreatic islets also have alpha cells that produce the hormone glucagon, which acts to raise glucose blood ...
Alpha-lactalbumin, a multifunctional milk protein, has emerged as a key player in the field of tumour biology. In its native state, the protein is primarily involved in lactose synthesis; however, ...
In recent years, we have come to appreciate that loss or dysfunction of insulin-producing islet beta cells underlies virtually all major forms of diabetes mellitus. In type 1 diabetes, beta cells ...
Nina Chamlou is a writer, interviewer and storyteller from Portland, Oregon. She covers technology, healthcare, psychology, mental health and social justice issues. Her motto is that useful info ...
The beta cells of the pancreas don’t need the assistance of other pancreatic cells to produce insulin, according to new research. The findings are not only a potential game-changer for diabetics, but ...